<< back
COVID-19 - Biopharma’s agility put at test
Research
Publication Date: 25 Mar 2020 - By Scitaris G. By Scitaris G.Thematic Multi Asset Global Biotechnology Pharmaceuticals
Scitaris, a leading biotech and pharma consultancy, is providing a perspective on the biological characteristics of the virus, including:
- implications on its transmission and potential ends to the pandemic
- focusing the race of the biopharma industry to finding a cure
- considerations for investors in the space
